copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home | Cancer Immunology, Immunotherapy - Springer Cancer Immunology, Immunotherapy is providing a timely and open access publication of original discovery and developments in basic and translational research in the field of cancer immunology and immunotherapy
Aims and scope | Cancer Immunology, Immunotherapy - Springer Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy
Updates | Cancer Immunology, Immunotherapy - Springer Cancer Immunology, Immunotherapy is now fully open access! We are excited to announce that Cancer Immunology, Immunotherapy has now become a fully open-access (OA) journal as of 5 th January 2024
Submission guidelines | Cancer Immunology, Immunotherapy Cancer Immunology, Immunotherapy welcomes suggestions of material as potential cover art After a manuscript is accepted for publication, the corresponding author may contact the Editor-in-Chief or the Editorial Office with suitable material that illustrates the significance impact of the paper
Breast Cancer Genetics, Immunology, and Immunotherapy: An . . . The sixth volume of the “Interdisciplinary Cancer Research” series, entitled “Breast Cancer Genetics, Immunology, and Immunotherapy: An Interdisciplinary Approach” publishes comprehensive volumes on immune and genetic mechanisms of breast cancer diagnosis and prognosis
Handbook of Cancer and Immunology | SpringerLink The Handbook of Cancer and Immunology offers a comprehensive and up-to-date review of cancer immunology and immunotherapy, emphasizing key findings and clinically relevant data
Cancer Immunology, Immunotherapy - Springer Dr Haidong Dong has more than two decades of research experience in cancer immunology and immunotherapy including the co-discovery of B7-H1 (PD-L1) and conceiving a method of B7-H1 targeting therapy for cancer